Paper17566582
An economical and highly productive cell-free protein synthesis system utilizing fructose-1,6-bisphosphate as an energy source.
Kim TW and 5 others. J Biotechnol, 2007. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. An economical and highly productive cell-free protein synthesis system utilizing fructose-1,6-bisphosphate as an energy source. Papers, record 17566582. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17566582
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- An economical and highly productive cell-free protein synthesis system utilizing fructose-1,6-bisphosphate as an energy source.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bioreactors | Major topic |
| Cell-Free System | Major topic |
| Escherichia coli | Major topic |
| Escherichia coli Proteins | Major topic |
| Fructosediphosphates | Major topic |
| Cell Culture Techniques | |
| Costs and Cost Analysis | |
| Energy Transfer | |
| Korea |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40859943 | A mathematical model of cell-free transcription-translation with plasmid crosstalk. | Synth Biol (Oxf) | 2025 | https://conductscience.org/library/papers/40859943 | PubMed |
| 39700225 | Cell-Free Gene Expression: Methods and Applications. | Chem Rev | 2025 | https://conductscience.org/library/papers/39700225 | PubMed |
| 39618802 | Cofactor recycling strategies for secondary metabolite production in cell-free protein expression systems. | Biophys Rev | 2024 | https://conductscience.org/library/papers/39618802 | PubMed |
| 38576719 | Engineering cell-free systems by chemoproteomic-assisted phenotypic screening. | RSC Chem Biol | 2024 | https://conductscience.org/library/papers/38576719 | PubMed |
| 38260740 | Influence of the mRNA initial region on protein production: a case study using recombinant detoxified pneumolysin as a model. | Front Bioeng Biotechnol | 2023 | https://conductscience.org/library/papers/38260740 | PubMed |
| 38247969 | A Cost-Effective Pichia pastoris Cell-Free System Driven by Glycolytic Intermediates Enables the Production of Complex Eukaryotic Proteins. | Bioengineering (Basel) | 2024 | https://conductscience.org/library/papers/38247969 | PubMed |
| 38094242 | Designing of an extract production protocol for industrial application of cell-free protein synthesis technology: Building from a current best practice to a quality by design approach. | Eng Biol | 2023 | https://conductscience.org/library/papers/38094242 | PubMed |
| 37526707 | Bottom-Up Synthetic Biology Using Cell-Free Protein Synthesis. | Adv Biochem Eng Biotechnol | 2023 | https://conductscience.org/library/papers/37526707 | PubMed |
| 37333859 | What remains from living cells in bacterial lysate-based cell-free systems. | Comput Struct Biotechnol J | 2023 | https://conductscience.org/library/papers/37333859 | PubMed |
| 37306703 | Solid-Phase Cell-Free Protein Synthesis and Its Applications in Biotechnology. | Adv Biochem Eng Biotechnol | 2023 | https://conductscience.org/library/papers/37306703 | PubMed |
| 37306701 | eCell Technology for Cell-Free Protein Synthesis, Biosensing, and Remediation. | Adv Biochem Eng Biotechnol | 2023 | https://conductscience.org/library/papers/37306701 | PubMed |
| 37306697 | Cell-Free Display Techniques for Protein Evolution. | Adv Biochem Eng Biotechnol | 2023 | https://conductscience.org/library/papers/37306697 | PubMed |
| 36548479 | A Low-Cost, Thermostable, Cell-Free Protein Synthesis Platform for On-Demand Production of Conjugate Vaccines. | ACS Synth Biol | 2023 | https://conductscience.org/library/papers/36548479 | PubMed |
| 35259873 | Constructing Cell-Free Expression Systems for Low-Cost Access. | ACS Synth Biol | 2022 | https://conductscience.org/library/papers/35259873 | PubMed |
| 35024094 | Key reaction components affect the kinetics and performance robustness of cell-free protein synthesis reactions. | Comput Struct Biotechnol J | 2022 | https://conductscience.org/library/papers/35024094 | PubMed |
| 32995514 | Elucidating the potential of crude cell extracts for producing pyruvate from glucose. | Synth Biol (Oxf) | 2018 | https://conductscience.org/library/papers/32995514 | PubMed |
| 32391815 | Preparing Protein Producing Synthetic Cells using Cell Free Bacterial Extracts, Liposomes and Emulsion Transfer. | J Vis Exp | 2020 | https://conductscience.org/library/papers/32391815 | PubMed |
| 31681738 | Exploring the Potential of Cell-Free Protein Synthesis for Extending the Abilities of Biological Systems. | Front Bioeng Biotechnol | 2019 | https://conductscience.org/library/papers/31681738 | PubMed |
| 29900421 | Cell-free protein synthesis enabled rapid prototyping for metabolic engineering and synthetic biology. | Synth Syst Biotechnol | 2018 | https://conductscience.org/library/papers/29900421 | PubMed |
| 29062966 | Bacterial cell-free expression technology to in vitro systems engineering and optimization. | Synth Syst Biotechnol | 2017 | https://conductscience.org/library/papers/29062966 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17566582
GET https://conductscience.org/api/papers/v1/17566582/cited_by?page=2